Skip to main content
Home

Breadcrumb

  1. Home
  2. Research

Research

25 August 2026

New Technologies and Building Successful Biotechnology Companies to Treat Disease

This event will explore how fundamental scientific discovery can be translated into real‑world benefit and the role universities play in supporting that journey with integrity, responsibility, and long‑term vision. ...

24 August 2026

The Art of Floristry

Spring low arrangement workshop with expert florists. Includes seasonal blooms, vessel & fizz. Create and take home your own elegant design ...

Presentation slide of Management and resolution of Challenging Behaviours after Acquired Brain Injury
7 May 2026

Clement Mind presents at UKABIF 2026: Managing Challenging Behaviours after Acquired Brain Injury

Dr Alberto Bonilla Miralles, Clinical & Occupational Psychologist and Director at Clement Mind, delivered a specialist presentation at the UK Acquired Brain Injury Forum (UKABIF) on evidence-based approaches to understanding and managing challenging behaviours following an acquired ...

aru building
5 May 2026

Nature loss brings catastrophic risks – ARU report

Food security is under threat, which could lead to economic and social instability. ...

Chris Aylott, Deloitte Partner and Life Sciences Catalyst lead
5 May 2026

Weight loss drugs boom drives pharma R&D returns, but industry could face ‘bubble’ effect

Top global pharma companies’ return on R&D increased for third consecutive year; Growth is almost entirely driven by GLP-1 drugs - used to treat obesity and diabetes - and accounts for 38% of projected sales;Obesity drugs have displaced oncology drugs as the largest contributor to t...

aveva logo
5 May 2026

AVEVA to invest c.£30million in Cambridge Research and Development hub to support future growth

Global industrial software leader to consolidate its Cambridge teams at Science Park global HQ ahead of a 2027 opening, reinforcing its long-term commitment to the city and its Industrial Intelligence strategy. ...

Retinitis pigmentosa
7 May 2026

12 gene therapies converge on retinitis pigmentosa and a $3.4bn market by 2033

This month Gene Scope Intelligence (www.genescope-intelligence.com), a dedicated gene therapy market intelligence platform releases a brand new commercial analysis and demand forecast for new gene therapies directed at Retinitis Pigmentosa (RP). ...

24 August 2026

Patient Engagement & Communication Drop-in with PhiZ & Co.

How do you ensure your research, clinical plans, and communications reflect what matters most to patients?Whether you're in early discovery, preparing for clinical development, or already running studies, bringing in patient insight early can help strengthen decisions, improve study des...

24 August 2026

The Common Thread — Monthly Networking Morning

Kickstart your day by connecting with brilliant people and opening doors to new opportunities.Join us at University Arms, in collaboration with the wonderful Neil Bharadwa at The Cambridge Fruit Company, for The Common Thread. A relaxed monthly networking morning bringing together Cambr...

24 August 2026

The Common Thread — Monthly Networking Morning

Kickstart your day by connecting with brilliant people and opening doors to new opportunities.Join us at University Arms, in collaboration with the wonderful Neil Bharadwa at The Cambridge Fruit Company, for The Common Thread. A relaxed monthly networking morning bringing together Cambr...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS